Adverse drug reactions Flashcards
Discuss the frequency of Adverse Drug Reactions (ADRs)
4th cause of death in UK and US.
5% of admissions to hospital are due to ADRS.
10-20% of patients will suffer from an ADR in hospital.
Define an ADR
ADR: any response to a drug which is noxious, unintended and used at doses for prophylaxis, diagnosis and treatment.
Discuss the mechanisms and role of differing disease states in the occurrence of Type A ADRs.
- Differential diagnosis
- history of medication
- relate to dose and beginning of treatment
- lab tests ( plasma concentration, allergies)
Discuss the methods available for detection and reporting of ADRs.
Yellow cards: reporting any abnormal reaction to a drug. Allow abnormal patterns to be detected.
Onset and severity of ADR
Onset:
-acute: within 60 minutes - bronchoconstriction
-sub-acute: 1-24 hours- serum sickness/rash
-latent: over 2 days
Severity:
-severe : severe life threatening consequences
-Mild : may need to be hospitalised. doses reduced
-moderated: mild discomfort but no major changes required.
Type A
Augumented- predictable
-pharmacokinetic/ pharmacodynamic/ pharmacogenetics/ prescription errors
e.g. bradychardia with beta blockers
hypoglycaemia with insulin
Type B
Bizarre- unpredictable
Causes:
-Idiosynchratic- due to abnormal receptors/enzymes
-Allergy- first dose of drug acts as an antigen- antigen/antibody complexes formed
-Increased probability with Macromolecules (e.g. vaccines, proteins), HLA genes, asthma and eczema patients
Type C
Chronic- semi-predictable
Osteoporosis- extended steroid treatment
Type D
Delayed
Carcinogenesis
Teratogenesis- fetus congenital malformation relating to drugs taken during first trimester
Type E
End of treatment
Addisons- end of steroid treatment
Epilepsy- withdrawal from alcohol
MI- beta blockers removed
Type F
Failure of treatment
Example of receptor abnormality and enzyme abnormality in type B
Receptor abnormality:
Malignany hyperthermia with anaestetics
Enzyme abnormality:
G6PD Deficiency- increased risk of red cell haemolysis when given primaquine